rhenium has been researched along with Carcinoma, Renal Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boerman, OC; Brouwers, AH; Corstens, FH; Frielink, C; Oosterwijk, E; Oyen, WJ; van Eerd, JE | 1 |
| Boerman, OC; Corstens, FH; Debruyne, FM; Kranenborg, MH; Oosterwijk, E; Steffens, MG; Zegwaart-Hagemeier, NE | 1 |
2 other study(ies) available for rhenium and Carcinoma, Renal Cell
| Article | Year |
|---|---|
Optimization of radioimmunotherapy of renal cell carcinoma: labeling of monoclonal antibody cG250 with 131I, 90Y, 177Lu, or 186Re.
Topics: Animals; Antibodies, Monoclonal; Carcinoma, Renal Cell; Humans; Iodine Radioisotopes; Isotope Labeling; Kidney Neoplasms; Lutetium; Mice; Mice, Nude; Pentetic Acid; Radioimmunotherapy; Radioisotopes; Rhenium; Tissue Distribution; Yttrium Radioisotopes | 2004 |
Tumor retention of 186Re-MAG3, 111In-DTPA and 125I labeled monoclonal antibody G250 in nude mice with renal cell carcinoma xenografts.
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Agents; Carcinoma, Renal Cell; Humans; Indium Radioisotopes; Iodine Radioisotopes; Kidney Neoplasms; Mice; Mice, Nude; Oligopeptides; Organometallic Compounds; Pentetic Acid; Radiopharmaceuticals; Rhenium; Tissue Distribution; Transplantation, Heterologous; Tumor Cells, Cultured | 1998 |